Dataset Information


Loss of miR-449a in ERG-associated prostate cancer promotes the invasive phenotype by inducing SIRT1.

ABSTRACT: Epigenetic regulation by SIRT1, a multifaceted NAD+-dependent protein deacetylase, is one of the most common factors modulating cellular processes in a broad range of diseases, including prostate cancer (CaP). SIRT1 is over-expressed in CaP cells, however the associated mechanism is not well understood. To identify whether specific microRNAs might mediate this linkage, we have screened a miRNA library for differential expression in ERG-associated CaP tissues. Of 20 differentially and significantly expressed miRNAs that distinguish ERG-positive tumors from ERG-negative tumors, we find miR-449a is highly suppressed in ERG-positive tumors. We establish that SIRT1 is a direct target of miR-449a and is also induced by ERG in ERG-associated CaP. Our data suggest that attenuation of miR-449a promotes the invasive phenotype of the ERG-positive CaP in part by inducing the expression of SIRT1 in prostate cancer cells. Furthermore, we also find that suppression of SIRT1 results in a significant reduction in ERG expression in ERG-positive CaP cells, indicating a feed-back regulatory loop associated with ERG, miR-449a and SIRT1. We also report that ERG suppresses p53 acetylation perhaps through miR-449a-SIRT1 axis in CaP cells. Our findings provide new insight into the function of miRNAs in regulating ERG-associated CaP. Thus, miR-449a activation or SIRT1 suppression may represent new therapeutic opportunity for ERG-associated CaP.


PROVIDER: S-EPMC5008401 | BioStudies | 2016-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC6197768 | BioStudies
2015-01-01 | S-EPMC5528701 | BioStudies
2017-01-01 | S-EPMC5587792 | BioStudies
1000-01-01 | S-EPMC4633902 | BioStudies
2013-01-01 | S-EPMC5427883 | BioStudies
2016-01-01 | S-EPMC4890029 | BioStudies
1000-01-01 | S-EPMC4924656 | BioStudies
2018-01-01 | S-EPMC5992482 | BioStudies
2010-01-01 | S-EPMC2952964 | BioStudies
2019-01-01 | S-EPMC6433048 | BioStudies